The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

Back in 2021, Vertex already said its intellectual property supported its leadership in the space into the late 2030s. All of this means there's reason to be confident about Vertex's ongoing ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Pivoting to Greater Boston’s next growth sectors has sustained Columbia Construction during a century of activity in the ...

Crypto payment firm RedotPay has closed a $40 million Series A funding round, led by Lightspeed with investments from HSG, ...

T he main attraction in the Wembley neighborhood of northwest London is the eponymous football stadium where the England ...

The parents of a seven-year-old boy who died in a clinical trial have spoken of their "indescribable" pain. Ender Nihat, from Essex, suffered organ failure after receiving chemotherapy during ...

Other unsolved mathematical mysteries are akin to the branches of trees. The trees themselves—fields within the wider subject ...

Officers, 10% owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks in the ...

Aashima Gupta leads health tech projects for the massive cloud computing company. Here, she shares why she’s excited about ...